Rebooted and Rising

. May 29, 2013.
Esperion-logo

The rebooted Ann Arbor drug development company, Esperion, closed on $33 million funding round last month just before reporting the success of its Phase 2 clinical trials of its cholesterol lowering therapy. Esperion was resurrected by its original founder Roger Newton, who relicensed its name and intellectual property in 2008 from Pfizer.

The company is developing a therapy from the molecule ETC-1002 that targets low-density lipoprotein (LDL), the so-called bad cholesterol that endangers the health of 9 million people. Company officials reported that its therapy lowered LDL cholesterol up to 43 percent in Phase 2 trials.

The funding will allow the company to continue trials and, analysts speculate, take the company public next year.

Newton, who started the original Esperion, led the team that developed Lipitor. He sold the company to Pfizer in 2004 for $1.3 billion. Pfizer eventually shut the company down, allowing Newton to buy back the patent for ETC-1002 for $22.75 million. Esperion is based in the Michigan Life Science and Innovation Center incubator in Plymouth Township.

Trending

Pioneer Students Walk Out of Classes at Noon

Students show support for Florida students anti-gun measures

Michigan Music Mix for Valentine’s Day!

Love is bliss. Love is pain. Love is catharsis and it’s messy and it’s marvelous. Love is the greatest and worst thing, ever. Love has inspired more songs than anything else in the history of humans making music to express their feelings. Whether you have it in abundance or if its just freshly fallen apart,

Musician Seth Bernard Launches Clean Water Campaign

  Singer/songwriter Seth Bernard is as well known for his music as he is for his community advocacy. The Earthwork Music founder recently released his third album in almost as many years, Eggtones for Fun, a break of brief levity spiced with a blend of sweet folk songs, strummy waltzes and some headier/heavier rock dirges,

UM’s Racial tension

My first few months at UM have been disappointing and scary